Sign in
4/A

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-091746

Options or other derivatives

  • President & CEO acquired 123,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-12-15 Grant or award : show line 1 in the form Restricted Stock Unit +67,500 2023-12-14 67,500 67,500 D
2015-12-15 Grant or award : show line 2 in the form Stock Option +56,250 $15.55 2023-12-14 56,250 56,250 D
Loading xslF345X03/doc4a.xml…